Hepatocellular Carcinoma | The Implications of Recent Data Sets for the Management of Hepatocellular Carcinoma

Featuring perspectives from Dr Ghassan Abou-Alfa and Dr Daneng Li, including the following topics:

• Introduction: Etiology of Hepatocellular Carcinoma (HCC) and IO Response (0:00)
• First-Line Therapy for Advanced HCC — Dr Abou-Alfa (17:42)
• Second- and Later-Line Therapy for Advanced HCC; Emerging Considerations for Patients with Resectable HCC — Dr Li (38:12)

CME information and select publications